ArticleBlood2018

Ciurea SO, Schafer JR, Bassett R, et al. Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantation.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.